Ryman Healthcare Limited

Ryman Healthcare Limited

RYHTY
Ryman Healthcare LimitedUS flagOther OTC
6.11
USD
- -
- -
1.24BMarket Cap
Ryman Healthcare Limited
RYHTY
(Other OTC)

Recent

price

6.11

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.97
1.15
1.37
1.6
1.79
2
2.31
2.56
3.02
3.38
3.75
4.01
4.47
5.11
4.45
5.03
Revenue per Share
0.7
0.89
1.07
1.21
1.73
2.15
2.71
3.17
3.44
2.89
2.35
3.75
6.15
2.35
0.03
-3.08
Basic EPS, GAAP
1.07
0.95
0.84
1.47
1.36
0.99
1.62
1.16
-1.64
-1.39
-2.44
-2.03
-2.65
-2.96
-1.18
-0.75
Free Cash Flow per Basic Share
0.25
0.3
0.34
0.4
0.49
0.55
0.65
0.75
0.83
0.96
1.04
0.95
0.99
0.62
- -
- -
Dividend per Share
3.35
3.92
4.65
5.44
6.67
8.24
10.26
12.63
15.22
17.11
18.37
21.46
26.62
37.05
27.85
29.23
Book Value per Share
4.05
5.02
5.74
6.52
8.22
9.77
11.78
14.59
17.04
19.01
20.08
24.73
30.02
41.74
29.66
29.9
Tangible Book Value per Share
112
113
113
113
113
113
113
113
113
113
113
113
113
110
146
142
Basic Weighted Avg Shares
109
129
154
180
202
226
260
288
341
381
422
452
504
560
651
714
Sales/Revenue/Turnover
22.17
22.9
22.39
22.26
18.65
14.46
16.62
16.65
15.25
14.2
10.48
5.47
0.36
-3.53
-10.7
-16.57
Operating Margin (%)
5
6
7
8
9
11
13
15
21
23
29
32
36
47
44
48
Depreciation Expense
78
100
121
137
195
242
305
357
388
326
265
423
693
258
5
-437
Net Income, GAAP
6.44
2.53
7.21
9.02
4.17
0.05
1.26
1.73
0.16
1.04
- -
- -
4.05
- -
- -
- -
Effective Tax Rate (%)
71.88
77.6
78.36
75.8
96.49
107.15
117.44
123.69
113.99
85.57
62.71
93.51
137.54
46.03
0.73
-61.2
Profit Margin (%)
-6
-9
-13
-3
-153
-14
14
-56
143
144
84
373
160
329
441
-674
Working Capital
142
158
213
226
277
1,987
2,399
2,975
1,060
1,324
1,757
2,834
3,386
2,227
2,569
1,695
LT Debt
454
566
647
734
927
1,101
1,328
1,652
1,941
2,170
2,301
2,829
3,435
4,664
4,418
4,261
Total Equity
3.95
4.34
3.96
3.9
3.27
1.51
1.25
1.13
1.36
1.65
- -
- -
0.03
- -
- -
- -
Return on Invested Capital (%)
17.05
19.16
18.58
17.86
21.35
12.69
9.72
9.22
11.28
11.44
- -
- -
12.41
- -
- -
- -
Return on Capital (%)
22.35
24.5
25.02
24.04
28.55
28.81
29.31
27.66
24.74
17.9
13.24
18.85
25.58
7.3
0.12
-10.63
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.16%
14.26%
-3.54%
Free Cash Flow
-20.99%
-12.48%
-37.81%
Net Income, GAAP
-926.86%
-1,857.13%
-9,248.29%
Sales/Revenue/Turnover
12.24%
11.12%
9.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
560
2024
- -
- -
- -
- -
651
2025
- -
- -
- -
- -
714

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.35
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
-3.08

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.62
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Ryman Healthcare Limited, New Zealand's largest provider of retirement villages and aged care services, develops, owns and operates integrated retirement communities offering a continuum of care from independent living to hospital-level support; core products and services include independent townhouses and apartments, serviced apartments with daily meals and housekeeping, rest home care, dementia care and hospital-level care beds integrated within villages named after trailblazers; the company serves over 15,000 residents across 49 operational villages, with 7,800 staff supporting high-occupancy aged care facilities in New Zealand and Victoria, Australia. Founded in 1984 by John Ryder and Kevin Hickman and headquartered in Christchurch, New Zealand, Ryman Healthcare lists on the NZX (RYM) and ASX (with ticker RYHTY via ADR), employing a deferred management fee model where residents receive a capped refund upon departure. Recent developments include a $1.0 billion equity raise in February 2025 to reset its balance sheet, full refinancing of $2.0 billion bank facilities in November 2025 extending tenor to five years with improved covenants, dual listing on the ASX in October 2025 to broaden its investor base, first positive free cash flow of $56.2 million for 1H26 ended September 2025 driven by cost savings exceeding $40 million annualized, sales momentum with 704 occupation right agreements at higher 28.8% average deferred management fees, completion of Kevin Hickman main building and Nellie Melba final stage in July 2025, land sales including Park Terrace for $42 million and Mount Eliza for $35 million as part of a land bank review, appointment of Richard Stephenson as Chief Development and Property Officer effective early 2026, and lifted FY26 guidance for 1,300-1,400 sales and $50-60 million cost savings.

Company News

APIChat
  • Ryman Healthcare Limited (RYHTY) Analyst/Investor Day Transcript

  • Reviewing Ryman Healthcare (OTCMKTS:RYHTY) and CVS Health (NYSE:CVS)

  • Critical Contrast: Ryman Healthcare (OTCMKTS:RYHTY) and Enhabit (NYSE:EHAB)

  • Ryman Healthcare Limited (RYHTY) Q2 2026 Earnings Call Transcript

  • Ryman Healthcare Limited (RYHTY) Q4 2025 Earnings Call Transcript

  • Ryman Healthcare Limited (RYHTY) Q2 2025 Earnings Call Transcript

  • Ryman Healthcare Limited (RYHTY) Q4 2024 Earnings Call Transcript

  • Ryman Healthcare Limited (RYHTY) Q2 2024 Earnings Call Transcript